|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/705 | |
| C07K 7/06 | |||
| C07K 16/28 | |||
| A61K 39/395 | |||
| A61K 38/17 | |||
| G01N 33/50 | |||
| A61P 37/06 | |||
| A61P 37/00 | |||
| A61P 29/00 |
| (11) | Number of the document | 3224276 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15863095.4 |
| Date of filing the European patent application | 2015-11-17 | |
| (97) | Date of publication of the European application | 2017-10-04 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2015/051107 |
| Date | 2015-11-17 |
| (87) | Number | WO 2016/084062 |
| Date | 2016-06-02 |
| (30) | Number | Date | Country code |
| 201462083952 P | 2014-11-25 | US |
| (72) |
KARIN, Nathan, IL
WILDBAUM, Gizi, IL
|
| (73) |
Technion Research & Development Foundation Limited,
Senate House Technion City, 3200004 Haifa,
IL
|
| (54) | NOVEL EPITOPE AS A TARGET FOR THERAPY OF INFLAMMATORY AUTOIMMUNE DISEASES AND GRAFT REJECTION |
| NOVEL EPITOPE AS A TARGET FOR THERAPY OF INFLAMMATORY AUTOIMMUNE DISEASES AND GRAFT REJECTION |